Kenneth B. Lee Jr.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Mississauga, Ontario, Canada
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Alane P. Barnes, by power of attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kenneth B. Lee Jr.

Form 4 holding Director

EYENOVIA, INC.

Security class
Common Stock, par value $.0001
Shares / value
64,544
Estimated value
$87,780
Report date
16 Jun 2022
Price
$1.36
Ownership
Direct
Form 4 holding Director

BIOCRYST PHARMACEUTICALS INC

Security class
Automatic Stock Option Grant
Shares / value
39,072
Estimated value
Report date
13 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

EYENOVIA, INC.

Security class
Stock Option (right to buy)
Shares / value
30,769
Estimated value
Report date
16 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kenneth B. Lee Jr.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .